Evidence map›Paper›PMID 20061380›Full record

ArticleThe Journal of biological chemistry2010

MTMR4 attenuates transforming growth factor beta (TGFbeta) signaling by dephosphorylating R-Smads in endosomes.

Junjing Yu, Lei Pan, Xincheng Qin, Hua Chen, Youli Xu, Yeguang Chen, Hong Tang

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. TGF-β signaling in health, disease, and therapeutics.Signal transduction and targeted therapy · 2024
    Review
  6. Review
  7. Review
  8. Review
  9. TGFB1/INHBA Homodimer/Nodal-SMAD2/3 Signaling Network: A Pivotal Molecular Target in PDAC Treatment.Molecular therapy : the journal of the American Society of Gene Therapy · 2021
    Review
  10. Observational
  11. TGF-β Signaling.Biomolecules · 2020
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Posttranslational Regulation of Smads.Cold Spring Harbor perspectives in biology · 2016
    Review
  17. TGF-β Signaling from Receptors to Smads.Cold Spring Harbor perspectives in biology · 2016
    Review
  18. Article
  19. Article
  20. Crystallization and preliminary X-ray crystallographic analysis of the PH-GRAM domain of human MTMR4.Acta crystallographica. Section F, Structural biology communications · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Junjing YuKey Laboratory of Infection and Immunity of the Chinese Academy of Sciences, Institute of Biophysics, Beijing 100101, China.
Lei Pan
Xincheng Qin
Hua Chen
Youli Xu
Yeguang Chen
Hong Tang
Institute of Biophysics · CNTsinghua University · CNChinese Academy of Sciences · CNUniversity of Chinese Academy of Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Homeostasis of Smad phosphorylation at its C-terminal SXS motif is essential for transforming growth factor beta (TGFbeta) signaling. Whereas it is known that TGFbeta signaling can be terminated by phosphatases, which dephosphorylate R-Smads in the nucleus, it is unclear whether there are any cytoplasmic phosphatase(s) that can attenuate R-Smad phosphorylation and nuclear translocation. Here we demonstrate that myotubularin-related protein 4 (MTMR4), a FYVE domain-containing dual-specificity protein phosphatase (DSP), attenuates TGFbeta signaling by reducing the phosphorylation level of R-Smads in early endosomes. Co-immunoprecipitation experiments showed that endogenous MTMR4 interacts with phosphorylated R-Smads, and that this interaction is correlated with dephosphorylation of R-Smads. Further analysis showed that overexpression of MTMR4 resulted in the sequestration of activated Smad3 in the early endosomes, thus reducing its nuclear translocation. However, both point mutations at the conserved catalytic site of the phosphatase (MTMR4-C407S) and small interference RNA of endogenous Mtmr4 expression led to sustained Smad3 activation. This work therefore suggests that MTMR4 plays an important role in preventing the overactivation of TGFbeta signaling by dephosphorylating activated R-Smads that have been trafficked to early endosomes.

Indexed as

AnimalsAortaCell NucleusEndosomesEndothelial CellsGene Expression Regulation, EnzymologicHeLa CellsHomeostasisHumansKidneyPhosphorylationProtein Structure, TertiaryProtein Tyrosine Phosphatases, Non-ReceptorSignal TransductionSmad2 ProteinSmad3 ProteinMTMR4 protein, humanProtein Tyrosine Phosphatases, Non-ReceptorSmad2 ProteinSMAD2 protein, humanSmad3 ProteinSMAD3 protein, humanSmad Proteins, Receptor-RegulatedTransforming Growth Factor beta

Identifiers

PMID20061380
PMCPMC2832994
OpenAlexW2149886628

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.